HB debut with sterile isolator delivery to Vietnam

On June 26, Haier Biomedical delivered its first batch of sterile isolators to Phenikaa University Hospital in Vietnam, marking the product's debut in the international market. With this delivery, the hospital's portfolio of high-end medical equipment has now been fully upgraded to Haier Biomedical solutions, including its biosafety cabinets, ultra-low temperature freezers, and blood refrigerators. 

A benchmark for smart healthcare in Vietnam: China's solution makes global impact

As the strategic pillar of Vietnam's Phenikaa Group, Phenikaa University Hospital is establishing itself as a benchmark for modern healthcare in the country. It is building an integrated network of medical services, education, and research, supported by advanced technologies, digital management systems, and local academic resources. 

The recent delivery of Haier Biomedical's sterile isolators carries strategic significance. It demonstrates the company's globalization strategy—moving beyond single-market breakthroughs to building international competitiveness through technological collaboration and integrated systems. More importantly, it signifies that China's solution to smart healthcare has officially become a key part of infrastructure development in Vietnam's emerging medical sector, setting the stage for broader global adoption. 

Sterile isolator: A smart shield for biosafety

Haier Biomedical's sterile isolator is a versatile safety solution designed for a range of applications, including sterility testing, cell-based drug processing, small-batch production, and hazardous drug preparation. It can also seamlessly switch between positive and negative pressure modes to meet different operational needs. 

In terms of biosafety, the isolator features high airtightness and high-level protection, ensuring complete isolation between samples, personnel, and the external environment. This effectively eliminates cross-contamination risks, establishing a strong line of defense for clinical operations. 

For sterilization performance, it adopts advanced rapid dry heat sterilization technology, delivering a spore kill rate of up to 6 log reductions. This guarantees deep, thorough sterilization without blind spots, providing reliable protection for both medical samples and the surrounding workspace. 

Another standout feature is its intelligent monitoring system, which monitors key parameters such as internal airflow, pressure, temperature and humidity, cleanliness levels, and filter lifespan in real time. With full data traceability, it offers peace of mind for operators while greatly improving healthcare efficiency and quality. 

Haier Biomedical leads amid global competition

As the global biomedical industry enters an era of system-level competition, Haier Biomedical is accelerating its transformation from a "Made in China" to a key contributor in shaping global medical infrastructure, enabled by its deep-rooted technical expertise and strong capabilities in ecosystem integration. 

The adoption of Haier Biomedical's all-scenario healthcare solutions at Vietnam's Phenikaa University Hospital serves as a shining example—a beacon guiding the future of China's solution to smart healthcare. It demonstrates the company's ability to address real-world challenges such as biosafety and precise medical data monitoring, while delivering integrated, full-scenario smart healthcare solutions that raise medical standards and improve quality of care worldwide. 

To choose Haier Biomedical is to step into the future of smart healthcare—advanced, secure, and efficient—ushering in a new era for the medical industry.